Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irving Kaplan

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Urologic Oncology|July 27, 2023
Conditional survival following radical cystectomy for urothelial carcinoma of the bladderMaria F Moreno, Sumedh Kaul, Aaron Fleishman, et al.
International Journal of Radiation Oncology, Biology, Physics|July 20, 2002
A pilot study of topical intrarectal application of amifostine for prevention of late radiation rectal injuryEdgar Ben-Josef, Sue Han, Martin Tobi, et al.
International Journal of Radiation Oncology, Biology, Physics|April 15, 2008
Organ deformation and dose coverage in robotic respiratory-tracking radiotherapyXing-Qi Lu, Lakshmi Narayan Shanmugham, Anand Mahadevan, et al.
Journal of Contemporary Brachytherapy|April 3, 2015
Improved dosimetry in prostate brachytherapy using high resolution contrast enhanced magnetic resonance imaging: a feasibility studyKaren Buch, Tye Morancy, Irving Kaplan, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 9, 2026
Diabetes Is an Independent Risk Factor for Radiation-Induced Hematuria After Robotic Stereotactic Body Radiotherapy for Prostate CancerLucia Elting, Jamil Almohtasib, Ignacio F San Francisco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2003
Time course and predictors of symptoms after primary prostate cancer therapyJames A Talcott, Judithy Manola, Jack A Clark, et al.
Cancer|December 22, 2017
Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK)Shankar Siva, Alexander V Louie, Andrew Warner, et al.
The Journal of Urology|February 12, 2019
Stereotactic Radiotherapy as a Treatment Option for Renal Tumors in the Solitary Kidney: A Multicenter Analysis from the IROCKRohann J M Correa, Alexander V Louie, Michael Staehler, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2013
Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: the PROSTQA experienceDaniel A Hamstra, Anna S C Conlon, Stephanie Daignault, et al.
Journal of Neuro-Oncology|May 17, 2003
A critical examination of the results from the Harvard-MIT NCT program phase I clinical trial of neutron capture therapy for intracranial diseasePaul M Busse, Otto K Harling, Matthew R Palmer, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Urologic Oncology|July 27, 2023
Conditional survival following radical cystectomy for urothelial carcinoma of the bladderMaria F Moreno, Sumedh Kaul, Aaron Fleishman, et al.
International Journal of Radiation Oncology, Biology, Physics|July 20, 2002
A pilot study of topical intrarectal application of amifostine for prevention of late radiation rectal injuryEdgar Ben-Josef, Sue Han, Martin Tobi, et al.
International Journal of Radiation Oncology, Biology, Physics|April 15, 2008
Organ deformation and dose coverage in robotic respiratory-tracking radiotherapyXing-Qi Lu, Lakshmi Narayan Shanmugham, Anand Mahadevan, et al.
Journal of Contemporary Brachytherapy|April 3, 2015
Improved dosimetry in prostate brachytherapy using high resolution contrast enhanced magnetic resonance imaging: a feasibility studyKaren Buch, Tye Morancy, Irving Kaplan, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 9, 2026
Diabetes Is an Independent Risk Factor for Radiation-Induced Hematuria After Robotic Stereotactic Body Radiotherapy for Prostate CancerLucia Elting, Jamil Almohtasib, Ignacio F San Francisco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2003
Time course and predictors of symptoms after primary prostate cancer therapyJames A Talcott, Judithy Manola, Jack A Clark, et al.
Cancer|December 22, 2017
Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK)Shankar Siva, Alexander V Louie, Andrew Warner, et al.
The Journal of Urology|February 12, 2019
Stereotactic Radiotherapy as a Treatment Option for Renal Tumors in the Solitary Kidney: A Multicenter Analysis from the IROCKRohann J M Correa, Alexander V Louie, Michael Staehler, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2013
Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: the PROSTQA experienceDaniel A Hamstra, Anna S C Conlon, Stephanie Daignault, et al.
Journal of Neuro-Oncology|May 17, 2003
A critical examination of the results from the Harvard-MIT NCT program phase I clinical trial of neutron capture therapy for intracranial diseasePaul M Busse, Otto K Harling, Matthew R Palmer, et al.
Pageof 4